Encrantz Staffan (CIK 1870875) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-11). Recent activity: Buy SGHT (14,100 shares), Buy SGHT (28,261 shares), Buy SGHT (13,958 shares), Buy SGHT (21,674 shares), Buy SGHT (40,951 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Sight Sciences, Inc. (SGHT) | Director | Buy | 14,100 | $68,794 |
| 2026-06-05 | Sight Sciences, Inc. (SGHT) | Director | Buy | 28,261 | $0 |
| 2025-12-18 | Sight Sciences, Inc. (SGHT) | Director | Buy | 13,958 | $115,991 |
| 2025-06-06 | Sight Sciences, Inc. (SGHT) | Director | Buy | 21,674 | $90,381 |
| 2025-06-06 | Sight Sciences, Inc. (SGHT) | Director | Buy | 40,951 | $173,632 |
| 2025-06-06 | Sight Sciences, Inc. (SGHT) | Director | Buy | 30,952 | $0 |
| 2025-06-06 | Sight Sciences, Inc. (SGHT) | Director | Buy | 27,900 | $117,738 |
| 2025-06-03 | Sight Sciences, Inc. (SGHT) | Director | Buy | 42,753 | $156,904 |
| 2025-06-03 | Sight Sciences, Inc. (SGHT) | Director | Buy | 30,799 | $119,500 |
| 2025-06-03 | Sight Sciences, Inc. (SGHT) | Director | Buy | 25,230 | $100,163 |
| 2025-05-29 | Sight Sciences, Inc. (SGHT) | Director | Buy | 41,346 | $142,230 |
| 2025-05-29 | Sight Sciences, Inc. (SGHT) | Director | Buy | 26,715 | $94,037 |
| 2025-05-29 | Sight Sciences, Inc. (SGHT) | Director | Buy | 60,128 | $215,860 |
| 2025-03-13 | Sight Sciences, Inc. (SGHT) | Director | Buy | 120,000 | $303,600 |
| 2025-03-13 | Sight Sciences, Inc. (SGHT) | Director | Buy | 150,000 | $406,500 |
| 2025-03-13 | Sight Sciences, Inc. (SGHT) | Director | Buy | 243,000 | $673,110 |
Source: SEC Form 4 filings · as of 2026-06-11